Literature DB >> 17616641

Cul4A is required for hematopoietic stem-cell engraftment and self-renewal.

Binghui Li1, Nan Jia, David L Waning, Feng-Chun Yang, Laura S Haneline, Kristin T Chun.   

Abstract

Several hematopoietic stem-cell (HSC) regulators are controlled by ubiquitin-mediated proteolysis, so the ubiquitin pathway might modulate HSC function. However, this hypothesis has not been formally tested. Cul4A encodes a core subunit of one ubiquitin ligase. Whereas Cul4A-deficient embryos die in utero, Cul4A-haploinsufficient mice are viable but exhibit abnormal hematopoiesis (fewer erythroid and primitive myeloid progenitors). Given these data, we examined whether Cul4A(+/-) HSCs might also be impaired. Using bone marrow transplantation assays, we determined that Cul4A(+/-) HSCs exhibit defects in engraftment and self-renewal capacity. These studies are the first to demonstrate that ubiquitin-mediated protein degradation is important for HSC function. Further, they indicate that a Cul4A ubiquitin ligase targets for degradation one or multiple HSC regulators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616641      PMCID: PMC1988932          DOI: 10.1182/blood-2006-12-064154

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

1.  CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein.

Authors:  Yue Zhang; Giovanni Morrone; Jianxuan Zhang; Xiaoai Chen; Xiaoling Lu; Liang Ma; Malcolm Moore; Pengbo Zhou
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

Review 2.  Cell cycle inhibitors in normal and tumor stem cells.

Authors:  Tao Cheng
Journal:  Oncogene       Date:  2004-09-20       Impact factor: 9.867

3.  TMF/ARA160 is a BC-box-containing protein that mediates the degradation of Stat3.

Authors:  Erez Perry; Rachel Tsruya; Pavel Levitsky; Oz Pomp; Michal Taller; Shira Weisberg; Wendy Parris; Sarang Kulkarni; Hana Malovani; Tony Pawson; Sally Shpungin; Uri Nir
Journal:  Oncogene       Date:  2004-11-25       Impact factor: 9.867

4.  Quantitative assay for totipotent reconstituting hematopoietic stem cells by a competitive repopulation strategy.

Authors:  S J Szilvassy; R K Humphries; P M Lansdorp; A C Eaves; C J Eaves
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Loss of FancC function results in decreased hematopoietic stem cell repopulating ability.

Authors:  L S Haneline; T A Gobbett; R Ramani; M Carreau; M Buchwald; M C Yoder; D W Clapp
Journal:  Blood       Date:  1999-07-01       Impact factor: 22.113

6.  Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells.

Authors:  Sebastian Stier; Tao Cheng; Randolf Forkert; Christoph Lutz; David M Dombkowski; Jie Lin Zhang; David T Scadden
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

7.  Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets.

Authors:  J A F Marteijn; J H Jansen; B A van der Reijden
Journal:  Leukemia       Date:  2006-07-27       Impact factor: 11.528

Review 8.  A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin.

Authors:  Andrew R Willems; Michael Schwab; Mike Tyers
Journal:  Biochim Biophys Acta       Date:  2004-11-29

9.  CUL-4A is critical for early embryonic development.

Authors:  Binghui Li; Joseph C Ruiz; Kristin T Chun
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

10.  A phase 2 study of bortezomib in relapsed, refractory myeloma.

Authors:  Paul G Richardson; Bart Barlogie; James Berenson; Seema Singhal; Sundar Jagannath; David Irwin; S Vincent Rajkumar; Gordan Srkalovic; Melissa Alsina; Raymond Alexanian; David Siegel; Robert Z Orlowski; David Kuter; Steven A Limentani; Stephanie Lee; Teru Hideshima; Dixie-Lee Esseltine; Michael Kauffman; Julian Adams; David P Schenkein; Kenneth C Anderson
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

View more
  10 in total

1.  Hoxb4 transduction down-regulates Geminin protein, providing hematopoietic stem and progenitor cells with proliferation potential.

Authors:  Yoshinori Ohno; Shin'ichiro Yasunaga; Motoaki Ohtsubo; Sayaka Mori; Miyuki Tsumura; Satoshi Okada; Tomohiko Ohta; Kiyoshi Ohtani; Masao Kobayashi; Yoshihiro Takihara
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

2.  E3 ubiquitin ligase Cullin4B mediated polyubiquitination of p53 for its degradation.

Authors:  Anand Thirunavukarasou; Prachi Singh; Gokulapriya Govindarajalu; Venkateshwarlu Bandi; Sudhakar Baluchamy
Journal:  Mol Cell Biochem       Date:  2014-01-23       Impact factor: 3.396

3.  Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1.

Authors:  Jörn Lausen; Ole Pless; Fransisca Leonard; Olga N Kuvardina; Benjamin Koch; Achim Leutz
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

Review 4.  Functional analysis of Cullin 3 E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Zhiwei Wang; Brian J North; Kaixiong Tao; Xiangpeng Dai; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-11-08       Impact factor: 10.680

5.  Cullin 4A and 4B ubiquitin ligases interact with γ-tubulin and induce its polyubiquitination.

Authors:  Anand Thirunavukarasou; Gokulapriya Govindarajalu; Prachi Singh; Venkateshwarlu Bandi; Kannan Muthu; Sudhakar Baluchamy
Journal:  Mol Cell Biochem       Date:  2014-12-27       Impact factor: 3.396

6.  Cul4A is required for hematopoietic cell viability and its deficiency leads to apoptosis.

Authors:  David L Waning; Binghui Li; Nan Jia; Yahaira Naaldijk; W Scott Goebel; Harm HogenEsch; Kristin T Chun
Journal:  Blood       Date:  2008-03-13       Impact factor: 22.113

7.  The epigenetic regulator CXXC finger protein 1 is essential for murine hematopoiesis.

Authors:  Kristin T Chun; Binghui Li; Erika Dobrota; Courtney Tate; Jeong-Heon Lee; Shehnaz Khan; Laura Haneline; Harm HogenEsch; David G Skalnik
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

8.  Hematopoietic stem cell quiescence and function are controlled by the CYLD-TRAF2-p38MAPK pathway.

Authors:  Melania Tesio; Yilang Tang; Katja Müdder; Massimo Saini; Lisa von Paleske; Elizabeth Macintyre; Manolis Pasparakis; Ari Waisman; Andreas Trumpp
Journal:  J Exp Med       Date:  2015-03-30       Impact factor: 14.307

9.  Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells.

Authors:  Ming-Szu Hung; I-Chuan Chen; Liang You; David M Jablons; Ya-Chin Li; Jian-Hua Mao; Zhidong Xu; Jr-Hau Lung; Cheng-Ta Yang; Shih-Tung Liu
Journal:  J Cell Mol Med       Date:  2016-03-10       Impact factor: 5.310

Review 10.  CUL4A ubiquitin ligase: a promising drug target for cancer and other human diseases.

Authors:  Puneet Sharma; Alo Nag
Journal:  Open Biol       Date:  2014-02-12       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.